Similar articles

• Maximizing the value of genomics in the drug discovery and development process.

  Spence P. Spence P. Prog Drug Res. 2003;60:159-70. doi: 10.1007/978-3-0348-8012-1_5. Prog Drug Res. 2003. PMID: 12790342 Review.
• Organizational improvements to enhance modern clinical epidemiology.

  Califf RM, Ginsburg GS. Califf RM, et al. JAMA. 2008 Nov 19;300(19):2300-2. doi: 10.1001/jama.2008.638. JAMA. 2008. PMID: 19017917 No abstract available.
• Systems Medicine: The Future of Medical Genomics, Healthcare, and Wellness.

  Saqi M, Pellet J, Roznovat I, Mazein A, Ballereau S, De Meulder B, Auffray C. Saqi M, et al. Methods Mol Biol. 2016;1386:43-60. doi: 10.1007/978-1-4939-3283-2_3. Methods Mol Biol. 2016. PMID: 26677178 Review.
• Discovery 2003 marcus evans Summit. Emerging opportunities. 10-12 March 2003, Monte Carlo, Monaco.

  McGowran M. McGowran M. IDrugs. 2003 Apr;6(4):306-8. IDrugs. 2003. PMID: 12839001 No abstract available.
• Clonorchis sinensis and Clonorchiasis: The Relevance of Exploring Genetic Variation.

  Wang D, Young ND, Korhonen PK, Gasser RB. Wang D, et al. Adv Parasitol. 2018;100:155-208. doi: 10.1016/bs.apar.2018.03.006. Epub 2018 May 4. Adv Parasitol. 2018. PMID: 29753338 Review.